Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FEED NASDAQ:ICU NASDAQ:IINN NASDAQ:OSRH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFEEDNanovibronix$1.13-2.6%$1.65$0.99▼$17.40$4.29M1.59676,514 shs257,692 shsICUSeaStar Medical$4.20-8.7%$3.59$2.07▼$13.40$18.39M-1.0487,562 shs167,417 shsIINNInspira Technologies OXY B.H.N.$0.40-2.3%$0.50$0.34▼$1.65$14.56M2.16363,680 shs282,273 shsOSRHOSR$0.60-2.7%$0.54$0.38▼$1.79$21.65M0.8617.83 million shs1.12 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFEEDNanovibronix-2.59%-14.39%-28.03%-60.07%+112,999,900.00%ICUSeaStar Medical-8.70%-13.58%+12.00%+75.00%-65.85%IINNInspira Technologies OXY B.H.N.-2.30%-12.07%-16.69%-32.81%-26.04%OSRHOSR-2.69%-13.18%+14.94%+20.97%-48.72%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFEEDNanovibronix$1.13-2.6%$1.65$0.99▼$17.40$4.29M1.59676,514 shs257,692 shsICUSeaStar Medical$4.20-8.7%$3.59$2.07▼$13.40$18.39M-1.0487,562 shs167,417 shsIINNInspira Technologies OXY B.H.N.$0.40-2.3%$0.50$0.34▼$1.65$14.56M2.16363,680 shs282,273 shsOSRHOSR$0.60-2.7%$0.54$0.38▼$1.79$21.65M0.8617.83 million shs1.12 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFEEDNanovibronix-2.59%-14.39%-28.03%-60.07%+112,999,900.00%ICUSeaStar Medical-8.70%-13.58%+12.00%+75.00%-65.85%IINNInspira Technologies OXY B.H.N.-2.30%-12.07%-16.69%-32.81%-26.04%OSRHOSR-2.69%-13.18%+14.94%+20.97%-48.72%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFEEDNanovibronix 1.00SellN/AN/AICUSeaStar Medical 2.00Hold$8.0090.48% UpsideIINNInspira Technologies OXY B.H.N. 2.00Hold$2.00405.43% UpsideOSRHOSR 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest FEED, ICU, OSRH, and IINN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2026ICUSeaStar Medical Maxim GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy$6.00 ➝ $8.004/24/2026FEEDNanovibronix Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/21/2026ICUSeaStar Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/10/2026IINNInspira Technologies OXY B.H.N. Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/27/2026OSRHOSR Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFEEDNanovibronix$2.55M1.64N/AN/A$30.44 per share0.04ICUSeaStar Medical$1.23M13.66N/AN/A$2.75 per share1.53IINNInspira Technologies OXY B.H.N.$289K49.22N/AN/A$0.06 per share6.60OSRHOSR$2.91M7.24N/AN/A$4.95 per share0.12Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFEEDNanovibronix-$18.18M-$41.74N/AN/AN/A-712.30%-47.82%-38.06%N/AICUSeaStar Medical-$12.15M-$8.30N/AN/AN/A-828.62%-141.54%-93.76%N/AIINNInspira Technologies OXY B.H.N.-$13.22MN/AN/AN/AN/AN/AN/AN/AN/AOSRHOSR-$27.06M-$1.28N/AN/AN/A-363.26%-7.16%-5.37%N/ALatest FEED, ICU, OSRH, and IINN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026ICUSeaStar Medical-$0.8250-$0.90-$0.0750-$0.90$0.44 million$0.50 million5/13/2026Q1 2026OSRHOSRN/A-$0.09N/A-$0.09N/A$0.48 million4/15/2026Q4 2025FEEDNanovibronixN/A-$20.00N/A-$20.00N/A$0.31 million3/25/2026Q4 2025ICUSeaStar Medical-$0.97-$0.80+$0.17-$0.80$0.22 million$0.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthFEEDNanovibronixN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/AIINNInspira Technologies OXY B.H.N.N/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFEEDNanovibronixN/A1.090.74ICUSeaStar MedicalN/A3.633.61IINNInspira Technologies OXY B.H.N.0.081.561.30OSRHOSRN/A0.160.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFEEDNanovibronix16.39%ICUSeaStar Medical1.69%IINNInspira Technologies OXY B.H.N.12.72%OSRHOSR55.30%Insider OwnershipCompanyInsider OwnershipFEEDNanovibronix1.40%ICUSeaStar Medical0.70%IINNInspira Technologies OXY B.H.N.29.40%OSRHOSR60.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFEEDNanovibronix203.70 million3.65 millionN/AICUSeaStar Medical24.00 million3.97 millionNot OptionableIINNInspira Technologies OXY B.H.N.2035.95 million25.38 millionNot OptionableOSRHOSRN/A35.10 million13.83 millionN/AFEED, ICU, OSRH, and IINN HeadlinesRecent News About These CompaniesOSR Holdings, Inc. (NASDAQ:OSRH) Short Interest UpdateMay 13 at 1:06 AM | americanbankingnews.comEmerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price TargetMay 5, 2026 | accessnewswire.comAOSR Holdings, Inc. Common Stock (OSRH) SEC FilingsMay 2, 2026 | nasdaq.comOSRH stock rockets 60% on $815M immunotherapy deal — retail bulls eye $1 mark for the stockApril 30, 2026 | msn.comOSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026April 30, 2026 | accessnewswire.comAOSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM EuropeApril 29, 2026 | accessnewswire.comAOSR Holdings Appoints New COO to Bolster Healthcare FocusApril 22, 2026 | tipranks.comOSR Holdings, Inc.: OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible NoteApril 10, 2026 | finanznachrichten.deOSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible NoteApril 9, 2026 | accessnewswire.comAOSR Holdings Revises Global License Deal for VXM01April 2, 2026 | tipranks.comOSR Holdings, Inc.: OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026March 31, 2026 | finanznachrichten.deOSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026March 30, 2026 | wfxg.comWEmerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price TargetMarch 27, 2026 | accessnewswire.comAOSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent LevelMarch 23, 2026 | accessnewswire.comAOSR Holdings, Inc.: Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial OpportunitiesMarch 19, 2026 | finanznachrichten.deWoori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter TrialsMarch 19, 2026 | taiwannews.com.twTWoori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial OpportunitiesMarch 19, 2026 | accessnewswire.comAOSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic MomentumMarch 5, 2026 | accessnewswire.comAOSR Holdings, Inc. Common Stock (OSRH) Institutional HoldingsFebruary 3, 2026 | nasdaq.comOSR Holdings, Inc.: CEO Statement to ShareholdersFebruary 2, 2026 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines1 Stock Is Powering the AI Boom and the Next Farm SupercycleBy Jeffrey Neal Johnson | April 22, 2026Q1 2026 Telecom Wars: Analyst Eye 30% Gains in T-Mobile Post-EarningsBy Leo Miller | May 3, 2026The USMCA Review Is Coming: 3 Border-Sensitive Stocks to WatchBy Chris Markoch | May 8, 20263 Agriculture Stocks to Buy as Food Inflation Stays Elevated in 2026By Chris Markoch | April 20, 2026Industrial Buybacks: Top Homebuilding Supplier Leads Buyback IncreasesBy Leo Miller | May 11, 2026FEED, ICU, OSRH, and IINN Company DescriptionsNanovibronix NASDAQ:FEED$1.13 -0.03 (-2.59%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$1.14 +0.01 (+0.44%) As of 04:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. ... NanoVibronix' catheter-based products include the UroShield™ and NG-Shield™ devices that are both CE mark certified.SeaStar Medical NASDAQ:ICU$4.20 -0.40 (-8.70%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$4.24 +0.04 (+0.95%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.Inspira Technologies OXY B.H.N. NASDAQ:IINN$0.40 -0.01 (-2.30%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$0.41 +0.01 (+2.86%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.OSR NASDAQ:OSRH$0.60 -0.02 (-2.69%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$0.60 0.00 (-0.50%) As of 04:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
